IRIS
LOSURDO, GIUSEPPE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.276
AS - Asia 2.231
EU - Europa 1.474
SA - Sud America 541
AF - Africa 54
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 3
Totale 10.585
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.187
SG - Singapore 981
CN - Cina 503
BR - Brasile 482
RU - Federazione Russa 365
HK - Hong Kong 337
SE - Svezia 330
DE - Germania 214
VN - Vietnam 184
IT - Italia 140
GB - Regno Unito 107
FI - Finlandia 66
FR - Francia 61
CA - Canada 50
BE - Belgio 49
ID - Indonesia 39
IN - India 39
BD - Bangladesh 29
PL - Polonia 27
MX - Messico 25
AR - Argentina 24
ES - Italia 20
ZA - Sudafrica 20
IQ - Iraq 18
NL - Olanda 17
UA - Ucraina 16
JP - Giappone 14
TR - Turchia 14
IE - Irlanda 12
AT - Austria 11
PK - Pakistan 10
SA - Arabia Saudita 9
UZ - Uzbekistan 9
CI - Costa d'Avorio 8
EC - Ecuador 8
CO - Colombia 7
MA - Marocco 7
VE - Venezuela 7
AE - Emirati Arabi Uniti 6
KR - Corea 6
PE - Perù 6
RO - Romania 6
EG - Egitto 5
EU - Europa 5
AL - Albania 4
DZ - Algeria 4
IL - Israele 4
JM - Giamaica 4
LT - Lituania 4
MK - Macedonia 4
AU - Australia 3
AZ - Azerbaigian 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
JO - Giordania 3
LV - Lettonia 3
PY - Paraguay 3
TH - Thailandia 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
BB - Barbados 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
IR - Iran 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
MY - Malesia 2
OM - Oman 2
QA - Qatar 2
TW - Taiwan 2
BG - Bulgaria 1
BJ - Benin 1
BO - Bolivia 1
BW - Botswana 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GT - Guatemala 1
GY - Guiana 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MN - Mongolia 1
MW - Malawi 1
NI - Nicaragua 1
NP - Nepal 1
PA - Panama 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
Totale 10.585
Salva come PNG Salva come JPEG
Città #
Fairfield 869
Ashburn 727
Woodbridge 626
Singapore 488
Chandler 449
Houston 376
Hong Kong 336
Seattle 334
Wilmington 297
Cambridge 293
Ann Arbor 286
Nyköping 278
Beijing 193
New York 140
Dallas 130
Lawrence 88
Jacksonville 85
Roxbury 85
Los Angeles 71
Nanjing 67
Munich 58
Inglewood 54
Des Moines 52
Ho Chi Minh City 52
Brussels 49
Bari 47
São Paulo 45
Princeton 39
Brooklyn 37
Hanoi 34
Buffalo 33
Jakarta 32
Dearborn 31
San Diego 31
Santa Clara 30
Chicago 25
Frankfurt am Main 22
Warsaw 22
Atlanta 21
Nuremberg 21
Dong Ket 19
Denver 18
Hebei 18
Helsinki 18
Paris 18
The Dalles 17
Boardman 16
Columbus 16
Nanchang 16
Orem 15
Rio de Janeiro 15
Stockholm 15
Jiaxing 14
London 14
Montreal 14
Tianjin 14
Belo Horizonte 13
San Francisco 13
San Jose 13
Shenyang 13
Tokyo 13
Toronto 13
Brasília 12
Chennai 12
Council Bluffs 12
Dublin 12
Haiphong 12
Mexico City 12
Boston 10
Johannesburg 10
Curitiba 9
Dhaka 9
Milan 9
Pune 9
Redwood City 9
Abidjan 8
Da Nang 8
Falkenstein 8
Guangzhou 8
Hefei 8
Maringá 8
Phoenix 8
Poplar 8
Porto Alegre 8
Turku 8
Changsha 7
Ha Long 7
Hangzhou 7
Moscow 7
Querétaro 7
Shanghai 7
Ankara 6
Düsseldorf 6
Falls Church 6
Ottawa 6
Salvador 6
Tashkent 6
Thái Nguyên 6
Vienna 6
Zhengzhou 6
Totale 7.601
Salva come PNG Salva come JPEG
Nome #
Differences in dietary habits between patients with inflammatory bowel disease in clinical remission and a healthy population 180
Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis 174
Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors 172
Systematic review with meta-analysis: post-operative complications and mortality risk in liver transplant candidates with obesity. 167
Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients? 165
May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis? 164
Extra-intestinal manifestations of non-celiac gluten sensitivity: An expanding paradigm 164
Evolution of nonspecific duodenal lymphocytosis over 2 years of follow-up 155
Chemoprevention of inflammation-related colorectal cancer by silymarin-, acetyl-11-keto-beta-boswellic acid-, curcumin- and maltodextrin-enriched dietetic formulation in animal model 155
Tailored therapy guided by multichannel intraluminal impedance pH monitoring for refractory non-erosive reflux disease 135
Systematic review: Renin-angiotensin system inhibitors in chemoprevention of hepatocellular carcinoma 134
Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis 132
What Is the Optimal Follow-up Time to Ascertain the Safety of Proton Pump Inhibitors? 128
Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin? 123
Intestinal microbiota: The explosive mixture at the origin of inflammatory bowel disease? 121
Non steroidal anti-inflammatory drug induced damage on lower gastro-intestinal tract: is there an involvement of microbiota? 116
Predictivity of Autoimmune Stigmata for Gluten Sensitivity in Subjects with Microscopic Enteritis: A Retrospective Study 110
Inter-observer agreement of a new endoscopic score for ulcerative colitis activity: Preliminary experience 110
Curcumin and colorectal cancer: From basic to clinical evidences 109
Chronic viral hepatitis in a cohort of inflammatory bowel disease patients from southern Italy: A case-control study 109
Systematic review with meta-analysis: de novo non-alcoholic fatty liver disease in liver-transplanted patients 108
Prevalence and associated factors of obesity in inflammatory bowel disease: A case-control study 104
Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: What needs to be explored? 102
Helicobacter pylori primary and secondary genotypic resistance to clarithromycin and levofloxacin detection in stools: A 4-year scenario in Southern Italy 102
null 101
null 100
null 99
Seronegative celiac disease: where is the specific setting? 98
Optimizing proton pump inhibitors in Helicobacter pylori treatment: Old and new tricks to improve effectiveness 96
Breath tests for the non-invasive diagnosis of small intestinal bacterial overgrowth: A systematic review with meta-analysis 95
null 94
Acute pancreatitis in elderly patients: A retrospective evaluation at hospital admission 91
Histamine and histaminergic receptors in colorectal cancer: From basic science to evidence-based medicine 89
null 86
null 86
Low Molecular Weight Heparin in Portal Vein Thrombosis of Cirrhotic Patients: Only Therapeutic Purposes? 85
null 85
An uncommon etiology of pancreatitis after endoscopic ultrasound-guided fine needle aspiration 85
Silymarin, boswellic acid and curcumin enriched dietetic formulation reduces the growth of inherited intestinal polyps in an animal model 84
null 82
Role of concomitant therapy for Helicobacter pylori eradication: A technical note 82
Escherichia coli Nissle 1917 in ulcerative colitis treatment: Systematic review and meta-analysis 82
null 81
null 81
The spectrum of small intestinal lesions in patients with unexplained iron deficiency anemia detected by video capsule endoscopy 81
The puzzle of coccoid forms of helicobacter pylori: Beyond basic science 81
Assessment of body composition: Intrinsic methodological limitations and statistical pitfalls 81
null 80
null 79
null 79
Endoscopic stenting for colorectal cancer obstruction as a bridge-to-surgery strategy 79
The helper lymphocyte and mast cell immunohistochemical pattern in nonceliac gluten sensitivity 77
Human leukocyte antigen (Hla) haplotype does not influence the inflammatory pattern of duodenal lymphocytosis linked to irritable bowel syndrome 76
null 74
null 73
null 73
A case of severe transaminase elevation following a single ustekinumab dose with remission after drug withdrawal 73
null 72
null 72
Might helicobacter pylori play a role in allergic or cross-reaction related disorders? 72
null 71
null 71
The influence of small intestinal bacterial overgrowth in digestive and extra-intestinal disorders 71
null 70
Noninvasive molecular analysis of Helicobacter pylori: is it time for tailored first-line therapy? 70
null 70
null 70
Effect of Long-Term Proton Pump Inhibitor Use on Blood Vitamins and Minerals: A Primary Care Setting Study 69
null 69
null 69
A prospective trial in Saudi Arabia comparing the 14-day standard triple therapy with the 10-day sequential therapy for treatment of Helicobacter pylori infection: A further confirmation of geographic Weight 69
Letter: dose-response analysis revealed closer relationship between obesity and perioperative outcomes in patients after liver transplantation—Authors’ reply 69
Endothelial function and cardiovascular risk in patients with inflammatory bowel disease in remission phase 69
Editorial: liver transplantation in patients with non-alcoholic fatty liver disease and obesity—authors’ reply 68
Epstein-Barr Virus-Related hyperacute hepatitis: May intravenous Ster-Oids be an effective approach? 68
Checkpoint Inhibitor-Induced Colitis: An Update 67
null 67
Biological markers for non-celiac gluten sensitivity: A question awaiting for a convincing answer 67
Trends of Liver Stiffness in Inflammatory Bowel Disease with Chronic Hepatitis C 67
Serrated Colorectal Lesions: An Up-to-Date Review from Histological Pattern to Molecular Pathogenesis 66
null 66
Letter: Portal vein obstruction - Which subset of patients could benefit the most? 66
Concomitant and Bismuth Quadruple Therapy for Helicobacter pylori Eradication in Southern Italy: Preliminary Data from a Randomized Clinical Trial 65
Primary clarithromycin resistance to Helicobacter pylori: Is this the main reason for triple therapy failure? 65
Liver involvement in inflammatory bowel disease: What should the clinician know? 63
Mucosal molecular pattern of tissue transglutaminase and interferon gamma in suspected seronegative celiac disease at marsh 1 and 0 stages 62
Estrogen receptors in colorectal cancer: Facts, novelties and perspectives 62
null 59
null 59
null 59
Comparison of Transient Elastography and Point Shear Wave Elastography for Analysis of Liver Stiffness: A Prospective Study 58
null 58
Does infliximab short infusion have a beneficial impact on the quality of life in patients with inflammatory bowel diseases? A single centre prospective evaluation 58
Familial adenomatous polyposis small bowel surveillance: could indicators for video-capsule endoscopy be ascertained? 58
Validation of a new optical diagnosis training module to improve dysplasia characterization in inflammatory bowel disease: a multicenter international study 57
Empiric “Three-in-One” Bismuth Quadruple Therapy for Second-Line Helicobacter pylori Eradication: An Intervention Study in Southern Italy 56
Intestinal microbiota: the explosive mixture for inflammatory bowel disease pathogenesis? 55
null 54
Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing association 54
Empirical Second-Line Therapy in 5000 Patients of the European Registry on Helicobacter pylori Management (Hp-EuReg) 53
Totale 8.807
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.974
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.974
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021677 0 0 0 0 0 84 105 149 60 148 51 80
2021/2022670 66 10 14 17 45 70 20 32 52 62 115 167
2022/20231.115 148 187 85 74 90 169 21 134 152 5 32 18
2023/2024416 29 69 16 47 26 137 6 7 2 34 8 35
2024/20252.039 56 25 106 32 38 183 297 210 93 136 285 578
2025/20262.571 724 242 332 470 641 162 0 0 0 0 0 0
Totale 11.122